Pfizer Inc.: Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL
Recall reason: Lack of Assurance of Sterility-The potential for incomplete crimp seals.. Recalled by Pfizer Inc.. Distribution: US Nationwide and Puerto Rico.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot#: HJ7566; Exp 2025/05 Lot#: HN8747; Exp 2025/09 Lot#: HN8749; Exp 2025/09. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report